FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Eliquis® (apixaban) was associated with a lower rate of major bleeding, stroke and systemic thromboembolic events compared to a vitamin K antagonist. Results show Eliquis was associated with a lower rate of major bleeding and comparable rates of stroke and systemic thromboembolic events versus dabig...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2019-12-01
|
| Series: | Евразийский Кардиологический Журнал |
| Online Access: | https://www.heartj.asia/jour/article/view/353 |
| _version_ | 1797878947765026816 |
|---|---|
| author | article Editorial |
| author_facet | article Editorial |
| author_sort | article Editorial |
| collection | DOAJ |
| description | Eliquis® (apixaban) was associated with a lower rate of major bleeding, stroke and systemic thromboembolic events compared to a vitamin K antagonist. Results show Eliquis was associated with a lower rate of major bleeding and comparable rates of stroke and systemic thromboembolic events versus dabigatran or rivaroxaban. This late-breaking presentation is one of 11 Bristol-Myers Squibb-Pfizer Alliance abstracts being presented at the European Society of Cardiology Congress 2019. |
| first_indexed | 2024-04-10T02:41:22Z |
| format | Article |
| id | doaj.art-8027b82cf3324f5c9dcbbc3cc511f548 |
| institution | Directory Open Access Journal |
| issn | 2225-1685 2305-0748 |
| language | Russian |
| last_indexed | 2024-04-10T02:41:22Z |
| publishDate | 2019-12-01 |
| publisher | InterMedservice |
| record_format | Article |
| series | Евразийский Кардиологический Журнал |
| spelling | doaj.art-8027b82cf3324f5c9dcbbc3cc511f5482023-03-13T07:47:38ZrusInterMedserviceЕвразийский Кардиологический Журнал2225-16852305-07482019-12-0104166170352FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATIONarticle EditorialEliquis® (apixaban) was associated with a lower rate of major bleeding, stroke and systemic thromboembolic events compared to a vitamin K antagonist. Results show Eliquis was associated with a lower rate of major bleeding and comparable rates of stroke and systemic thromboembolic events versus dabigatran or rivaroxaban. This late-breaking presentation is one of 11 Bristol-Myers Squibb-Pfizer Alliance abstracts being presented at the European Society of Cardiology Congress 2019.https://www.heartj.asia/jour/article/view/353 |
| spellingShingle | article Editorial FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Евразийский Кардиологический Журнал |
| title | FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION |
| title_full | FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION |
| title_fullStr | FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION |
| title_full_unstemmed | FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION |
| title_short | FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION |
| title_sort | findings released from naxos a french real world data analysis and the largest real world data analysis on oral anticoagulant effectiveness and safety in europe among patients with non valvular atrial fibrillation |
| url | https://www.heartj.asia/jour/article/view/353 |
| work_keys_str_mv | AT articleeditorial findingsreleasedfromnaxosafrenchrealworlddataanalysisandthelargestrealworlddataanalysisonoralanticoagulanteffectivenessandsafetyineuropeamongpatientswithnonvalvularatrialfibrillation |